|
1.
|
H GustavssonK WelenJE DamberTransition of
an androgen-dependent human prostate cancer cell line into an
androgen-independent subline is associated with increased
angiogenesisProstate62364373200510.1002/pros.2014515389782
|
|
2.
|
Y NiuS AltuwaijriKP LaiAndrogen receptor
is a tumor suppressor and proliferator in prostate cancerProc Natl
Acad Sci USA1051218212187200810.1073/pnas.080470010518723679
|
|
3.
|
JN DavisKJ WojnoS DaignaultElevated E2F1
inhibits transcription of the androgen receptor in metastatic
hormone-resistant prostate cancerCancer
Res661189711906200610.1158/0008-5472.CAN-06-249717178887
|
|
4.
|
SO LeeSS DuttN NadimintyE PinderH LiaoAC
GaoDevelopment of an androgen-deprivation induced and androgen
suppressed human prostate cancer cell
lineProstate6712931300200710.1002/pros.2062117626246
|
|
5.
|
P SaraonK JarviEP DiamandisMolecular
alterations during progression of prostate cancer to androgen
independenceClin
Chem5713661375201110.1373/clinchem.2011.16597721956922
|
|
6.
|
HL DevlinM MudryjProgression of prostate
cancer: multiple pathways to androgen independenceCancer
Lett274177186200910.1016/j.canlet.2008.06.00718657355
|
|
7.
|
PA WatsonYF ChenMD BalbasConstitutively
active androgen receptor splice variants expressed in
castration-resistant prostate cancer require full-length androgen
receptorProc Natl Acad Sci
USA1071675916765201010.1073/pnas.1012443107
|
|
8.
|
TC YuanS VeeramaniFF LinAndrogen
deprivation induces human prostate epithelial neuroendocrine
differentiation of androgen-sensitive LNCaP cellsEndocr Relat
Cancer13151167200610.1677/erc.1.01043
|
|
9.
|
K ZhangDJ WaxmanPC3 prostate
tumor-initiating cells with molecular profile
FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesisMol
Cancer9319201010.1186/1476-4598-9-31921190562
|
|
10.
|
KM BaeZ SuC FryeExpression of pluripotent
stem cell reprogramming factors by prostate tumor initiating cellsJ
Urol18320452053201010.1016/j.juro.2009.12.09220303530
|
|
11.
|
AK RajasekaranG AnilkumarJJ ChristiansenIs
prostate-specific membrane antigen a multifunctional protein?Am J
Physiol Cell
Physiol288C975C981200510.1152/ajpcell.00506.200415840561
|
|
12.
|
SJ LeeK LeeX YangNFATc1 with AP-3 site
binding specificity mediates gene expression of
prostate-specific-membrane-antigenJ Mol
Biol330749760200310.1016/S0022-2836(03)00640-512850144
|
|
13.
|
A GhoshWD HestonTumor target prostate
specific membrane antigen (PSMA) and its regulation in prostate
cancerJ Cell Biochem91528539200410.1002/jcb.10661
|
|
14.
|
RS IsraeliCT PowellJG CorrWR FairWD
HestonExpression of the prostate-specific membrane antigenCancer
Res541807181119947511053
|
|
15.
|
T LiuLY WuMR HopkinsJK ChoiCE BerkmanA
targeted low molecular weight near-infrared fluorescent probe for
prostate cancerBioorg Med Chem
Lett2071247126201010.1016/j.bmcl.2010.09.05720947349
|
|
16.
|
JY MatrouleCM CarthyDJ GranvilleO JoloisDW
HuntJ PietteMechanism of colon cancer cell apoptosis mediated by
pyropheophorbide-a methylester
photosensitizationOncogene2040704084200110.1038/sj.onc.120454611494135
|
|
17.
|
T LiuLY WuCE BerkmanProstate-specific
membrane antigen-targeted photodynamic therapy induces rapid
cytoskeletal disruptionCancer
Lett296106112201010.1016/j.canlet.2010.04.00320452720
|
|
18.
|
T LiuY ToriyabeCE BerkmanPurification of
prostate-specific membrane antigen using conformational
epitope-specific antibody-affinity chromatographyProtein Expr
Purif49251255200610.1016/j.pep.2006.05.008
|
|
19.
|
T LiuLY WuM KazakCE BerkmanCell-surface
labeling and internalization by a fluorescent inhibitor of
prostate-specific membrane
antigenProstate68955964200810.1002/pros.2075318361407
|
|
20.
|
LY WuMO AndersonY ToriyabeThe molecular
pruning of a phosphoramidate peptidomimetic inhibitor of
prostate-specific membrane antigenBioorg Med
Chem1574347443200710.1016/j.bmc.2007.07.02817869524
|
|
21.
|
MO AndersonLY WuNM SantiagoSubstrate
specificity of prostate-specific membrane antigenBioorg Med
Chem1566786686200710.1016/j.bmc.2007.08.00617764959
|
|
22.
|
J MaungJP MallariTA GirtsmanProbing for a
hydrophobic a binding register in prostate-specific membrane
antigen with phenylalkylphosphonamidatesBioorg Med
Chem1249694979200410.1016/j.bmc.2004.06.031
|
|
23.
|
DA WolfT HerzingerH HermekingD BlaschkeW
HorzTranscriptional and posttranscriptional regulation of human
androgen receptor expression by androgenMol
Endocrinol792493619938413317
|
|
24.
|
Y NiuTM ChangS YehWL MaYZ WangC
ChangDifferential androgen receptor signals in different cells
explain why androgen-deprivation therapy of prostate cancer
failsOncogene2935933604201010.1038/onc.2010.12120440270
|
|
25.
|
JS RossCE SheehanHA FisherCorrelation of
primary tumor prostate-specific membrane antigen expression with
disease recurrence in prostate cancerClin Cancer
Res963576362200314695135
|
|
26.
|
S PernerMD HoferR KimProstate-specific
membrane antigen expression as a predictor of prostate cancer
progressionHum
Pathol38696701200710.1016/j.humpath.2006.11.01217320151
|
|
27.
|
JM KokontisN HayS LiaoProgression of LNCaP
prostate tumor cells during androgen deprivation:
hormone-independent growth, repression of proliferation by
androgen, and role for p27Kip1 in androgen-induced cell
cycle arrestMol
Endocrinol12941953199810.1210/mend.12.7.01369658399
|
|
28.
|
N IshikuraH KawataA NishimotoR NakamuraN
IshiiY AokiEstablishment and characterization of an androgen
receptor-dependent, androgen-independent human prostate cancer cell
line, LNCaP-CS10Prostate70457466201019902465
|
|
29.
|
H SuzukiT UedaT IchikawaH ItoAndrogen
receptor involvement in the progression of prostate cancerEndocr
Relat Cancer10209216200310.1677/erc.0.010020912790784
|
|
30.
|
A ChlenskiK NakashiroKV KetelsGI
KorovaitsevaR OyasuAndrogen receptor expression in
androgen-independent prostate cancer cell
linesProstate476675200110.1002/pros.104811304731
|
|
31.
|
P Mhawech-FaucegliaDJ SmiragliaW
BsharaProstate-specific membrane antigen expression is a potential
prognostic marker in endometrial adenocarcinomaCancer Epidemiol
Biomarkers Prev17571577200810.1158/1055-9965.EPI-07-0511
|
|
32.
|
A GhoshX WangE KleinWD HestonNovel role of
prostate-specific membrane antigen in suppressing prostate cancer
invasivenessCancer Res65727731200515705868
|
|
33.
|
Y TangAW HamburgerL WangMA KhanA
HussainAndrogen deprivation and stem cell markers in prostate
cancersInt J Clin Exp Pathol3128138200920126580
|
|
34.
|
A GhoshWD HestonEffect of carbohydrate
moieties on the folate hydrolysis activity of the prostate specific
membrane antigenProstate57140151200310.1002/pros.1028912949938
|
|
35.
|
EH HolmesTG GreeneWT TinoAnalysis of
glycosylation of prostate-specific membrane antigen derived from
LNCaP cells, prostatic carcinoma tumors, and serum from prostate
cancer
patientsProstateSuppl72529199610.1002/(SICI)1097-0045(1996)7+%3C25::AID-PROS3%3E3.0.CO;2-I
|
|
36.
|
C BarinkaP SachaJ SklenarIdentification of
the N-glycosylation sites on glutamate carboxypeptidase II
necessary for proteolytic activityProtein
Sci1316271635200410.1110/ps.0462210415152093
|
|
37.
|
R Luthi-CarterAK BarczakH SpenoJT
CoyleHydrolysis of the neuropeptide N-acetylaspartylglutamate
(NAAG) by cloned human glutamate carboxypeptidase IIBrain
Res795341348199810.1016/S0006-8993(98)00244-39622670
|
|
38.
|
CW TiffanyRG LapidusA MerionDC CalvinBS
SlusherCharacterization of the enzymatic activity of PSM:
comparison with brain
NAALADaseProstate392835199910.1002/(SICI)1097-0045(19990401)39:1%3C28::AID-PROS5%3E3.0.CO;2-A10221263
|
|
39.
|
R Luthi-CarterAK BarczakH SpenoJT
CoyleMolecular characterization of human brain N-acetylated
alpha-linked acidic dipeptidase (NAALADase)J Pharmacol Exp
Ther286102010251998
|
